Inhibitory effect of Emblica officinalis on the in vivo clastogenicity of benzo[a]pyrene and cyclophosphamide in mice

Human and Experimental Toxicology

Volumn 19, Issue 6, 2000, Pages 377-384

  Sharma, N ^a   Trikha, P ^a   Athar, M ^a   Raisuddin, S ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Antioxidant enzymes; Carcinogens; Emblica officinalis; Genotoxicity inhibition; Mutagenicity; Vitamin C

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; BENZO[A]PYRENE; CLASTOGEN; CYCLOPHOSPHAMIDE; CYTOCHROME P450; EMBLICA OFFICINALIS EXTRACT; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; LIVER ENZYME; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW; CARCINOGENICITY; CHROMOSOME ABERRATION; CONTROLLED STUDY; DETOXIFICATION; DRUG DISPOSITION; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; GENOTOXICITY; IN VIVO STUDY; MALE; MICRONUCLEUS TEST; MOUSE; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL;

EID: 0033812693     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1191/096032700678815945     Document Type: Article

References (54)

1. Cooking methods, carcinogens and diet-cancer studies
2. Vegetables, fruits, and cancer: I. Epidemiology
3. Chemoprevention of azoxymethane-induced rat colon carcinogenesis by the naturally occurring flavonoids, diosmin and hesperidin
4. Antimutagens and anticarcinogens in foods
5. Suppression of 7,12-dimethylbenz (α) anthracene-induced chromosome aberrations in rat bone marrow cells by vegetable juices
6. Ellagic acid inhibits DNA binding of benzo [α] pyrene activated by different modes
7. Inhibitory effect of dietary vegetables on the in vivo clastogenicity of cyclophosphamide
8. Protective effects of Cassia occidentalis extract on chemical-induced chromosomal aberrations in mice
9. A pilot study of svetaprada (leucorrhoea) with amalaka guggulu
10. Modification of clastogenicity of lead and aluminum in mouse bone marrow cells by dietary ingestion of Phyllanthus emblica fruit extract
11. Modification of metal induced micronuclei formation in mouse bone marrow erythrocytes by Phyllanthus fruit extract and ascorbic acid
12. Dietary chemoprevention of clastogenic effects of 3,4-benzo[a] pyrene by Emblica officinalis Gaertn. Fruit extract
13. Antioxidant activity of Emblica officinalis
14. Searches for ultimate chemical carcinogens and their reaction with cellular macromolecules
15. Genetic effects of cyclophosphamide, ifosfamide and trofosfamide
16. Induction of chromosome damage in mouse bone marrow by benzo[a] pyrene
17. Mammalian in vivo cytogenetic assays: Analysis of chromosome aberrations in bone marrow cells
18. Comparitive cytogenetic analysis of bone marrow damage induced in B6C3F mice by multiple exposures to gaseous 1,3-butadiene
19. The bone marrow micronucleus assay: Rationale for a revised protocol
20. Sister-chromatid exchange and micronucleus induction as indicators of genetic damage in maternal and foetal cells
21. The micronucleus test
22. Differential distribution of glutathione and glutathione related enzymes in rabbit kidney. Possible implications in analgesic neuropathy
23. Protein measurement with the Folin phenol reagent
24. The carbon monoxide binding pigment of liver microsomes, I. Evidence for its hemoprotein nature
25. Bromobenzene-induced liver necrosis: Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic intermediate
26. Glutathione S-transferase. The first enzymatic step in mercapturic acid formation
27. Glutathione reductase levels in rat brain
28. 4 induce DNA damage in human cells by indirect action
29. Transferable clastogenic activity in plasma from patients with Falconi anemia
30. The preventive and therapeutic potential of the squalene-containing compound, roidex, on tumor promotion and regression
31. Effect of ascorbic acid prophylaxis on the frequency of chromosome aberrations in the peripheral lymphocytes of coal-tar workers
32. Critical assessment of the epidemiological data concerning the impact of antioxidant nutrients on cancer and cardiovascular disease
33. Inhibitors of endogenous nitrosation. Mechanism of implications in human cancer prevention
34. Use of ascorbic acid to inhibit nitrosation: Kinetic and mass transfer for an in vivo system
35. Inhibition of estrogen-induced renal carcinoma in Syrian hamsters by vitamin C
36. Plant extracts as modulators of genotoxic effects
37. Effect of Emblica officinalis, Phyllanthus amarus and Picrorrhiza kurroa on N-nitrosodiethylamine induced hepatocarcinogenesis
38. Blocking the formation of N-nitroso compounds with ascorbic acid in vitro and in vivo
39. The action of anticlastogens in human lymphocytes cultures and their modification by rat-liver S9 mix II. Studies with vitamin C and E
40. Antagonistic activity of herbal drug (Phyllanthus emblica) on cytological effects of environmental chemicals on mammalian cells
41. Effect of chronic vanadium pentaoxide administration on L-ascorbic acid supplementation
42. Modifying role of Phyllanthus emblica and ascorbic acid against nickel clastogenicity in mice
43. Effect of ascorbic acid prophylaxis on the frequency of chromosome aberrations, urine mutagenicity and nucleolus test in workers occupationally exposed to cytostatic drugs
44. Inhibition of BaP and BaP-transdihydrodiol metabolism and DNA binding in mouse lung explants by ellagic acid
45. Extremely facile reaction between the ultimate carcinogen benzo(α)pyrene 7,8-diol-9,10-epoxide and ellagic acid
46. Modifying effects of the naturally occurring antioxidants γ-oryzanol, phytic acid, tannic acid and n-tritriacontane-16, 18-dione in a rat wide spectrum organ carcinogenesis model
47. Antimutagenic action of vegetable factors on the mutagenic principle of tryptophan pyrolysate
48. Bionutrition and oral cancer in humans
49. Vitamins as antimutagens: Advantages and some possible mechanisms of antimutagenic action
50. Chemoprevention of cancer
51. Cytochrome P-450 enzymes as targets for chemoprevention against chemical carcinogenesis and toxicity: Opportunities and limitations